| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.02 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.02 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |